Loading...
uPAR: a beacon of malignancy?
Discriminating between benign and malignant disease is a pivotal diagnostic issue in the care of women with pelvic masses. Soluble forms of urokinase plasminogen activator receptor (uPAR) represent a promising new tool in the development of a discriminatory biomarker panel that can influence patient...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2587046/ https://ncbi.nlm.nih.gov/pubmed/18794069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-1557 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|